Bioggio, Switzerland, 2 November 2009 -- Telormedix, a clinical stage biopharmaceutical company focused on targeted immunity in the treatment of cancer and other diseases, today announced the launch of its new corporate website.
It can be viewed at: www.telormedix.com
